Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003)

NCT01011725 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: MK 0773
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC